{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T22:42:26Z","timestamp":1790808146698,"version":"4.1.0"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2017,9,11]],"date-time":"2017-09-11T00:00:00Z","timestamp":1505088000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Sanofi-Pasteur MSD"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J. Neurovirol."],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1007\/s13365-017-0569-1","type":"journal-article","created":{"date-parts":[[2017,9,11]],"date-time":"2017-09-11T21:55:16Z","timestamp":1505166916000},"page":"839-844","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Prevalence of a history of prior varicella\/herpes zoster infection in multiple sclerosis"],"prefix":"10.1007","volume":"23","author":[{"given":"Ali","family":"Manouchehrinia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Radu","family":"Tanasescu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huner","family":"Kareem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oltita P.","family":"Jerca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fouzia","family":"Jabeen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachelle","family":"Shafei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judith","family":"Breuer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keith","family":"Neal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William","family":"Irving","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cris S.","family":"Constantinescu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,9,11]]},"reference":[{"issue":"Suppl 2","key":"569_CR1","doi-asserted-by":"crossref","first-page":"S58","DOI":"10.1086\/522123","volume":"197","author":"AM Arvin","year":"2008","unstructured":"Arvin AM (2008) Humoral and cellular immunity to varicella-zoster virus: an overview. J Infect Dis 197(Suppl 2):S58\u2013S60","journal-title":"J Infect Dis"},{"key":"569_CR2","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1001\/jamaneurol.2014.3065","volume":"72","author":"AM Arvin","year":"2015","unstructured":"Arvin AM, Wolinsky JS, Kappos L, Morris MI, Reder AT, Tornatore C, Gershon A, Gershon M, Levin MJ, Bezuidenhoudt M, Putzki N (2015) Varicella-zoster virus infections in patients treated with fingolimod: risk assessment and consensus recommendations for management. JAMA Neurol 72:31\u201339","journal-title":"JAMA Neurol"},{"key":"569_CR3","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1586\/14737175.2013.865866","volume":"13","author":"A Ascherio","year":"2013","unstructured":"Ascherio A (2013) Environmental factors in multiple sclerosis. Expert Rev Neurother 13:3\u20139","journal-title":"Expert Rev Neurother"},{"key":"569_CR4","doi-asserted-by":"crossref","first-page":"1942","DOI":"10.1212\/WNL.0b013e3182735edf","volume":"79","author":"D Bourdette","year":"2012","unstructured":"Bourdette D, Gilden D (2012) Fingolimod and multiple sclerosis: four cautionary tales. Neurology 79:1942\u20131943","journal-title":"Neurology"},{"issue":"e","key":"569_CR5","doi-asserted-by":"crossref","first-page":"7638","DOI":"10.1371\/journal.pone.0007638","volume":"4","author":"J Brettschneider","year":"2009","unstructured":"Brettschneider J, Tumani H, Kiechle U, Muche R, Richards G, Lehmensiek V, Ludolph AC, Otto M (2009) IgG antibodies against measles, rubella, and varicella zoster virus predict conversion to multiple sclerosis in clinically isolated syndrome. PLoS One 4(e):7638","journal-title":"PLoS One"},{"key":"569_CR6","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1212\/WNL.0000000000000038","volume":"82","author":"J Breuer","year":"2014","unstructured":"Breuer J, Pacou M, Gauthier A, Brown MM (2014) Herpes zoster as a risk factor for stroke and TIA: a retrospective cohort study in the UK. Neurology 82:206\u2013212","journal-title":"Neurology"},{"key":"569_CR7","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1016\/S0140-6736(08)61620-7","volume":"372","author":"A Compston","year":"2008","unstructured":"Compston A, Coles A (2008) Multiple sclerosis. Lancet 372:1502\u20131517","journal-title":"Lancet"},{"key":"569_CR8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1017\/S0950268803001523","volume":"132","author":"DM Fleming","year":"2004","unstructured":"Fleming DM, Cross KW, Cobb WA, Chapman RS (2004) Gender difference in the incidence of shingles. Epidemiol Infect 132:1\u20135","journal-title":"Epidemiol Infect"},{"issue":"Suppl 2","key":"569_CR9","first-page":"89A","volume":"11","author":"D Gilden","year":"2004","unstructured":"Gilden D (2004) Varicella zoster virus and central nervous system syndromes. Herpesviridae 11(Suppl 2):89A\u201394A","journal-title":"Herpesviridae"},{"key":"569_CR10","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1097\/BOR.0000000000000292","volume":"28","author":"D Gilden","year":"2016","unstructured":"Gilden D, Nagel MA (2016) Varicella zoster virus triggers the immunopathology of giant cell arteritis. Curr Opin Rheumatol 28:376\u2013382","journal-title":"Curr Opin Rheumatol"},{"key":"569_CR11","doi-asserted-by":"crossref","first-page":"835","DOI":"10.3181\/00379727-149-38909","volume":"149","author":"M Ito","year":"1975","unstructured":"Ito M, Barron AL, Olszewski WA, Milgrom F (1975) Antibody titers by mixed agglutination to varicella-zoster, herpes simplex and vaccinia viruses in patients with multiple sclerosis. Proc Soc Exp Biol Med 149:835\u2013839","journal-title":"Proc Soc Exp Biol Med"},{"key":"569_CR12","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1093\/infdis\/jir239","volume":"204","author":"JH Kang","year":"2011","unstructured":"Kang JH, Sheu JJ, Kao S, Lin HC (2011) Increased risk of multiple sclerosis following herpes zoster: a nationwide, population-based study. J Infect Dis 204:188\u2013192","journal-title":"J Infect Dis"},{"key":"569_CR13","doi-asserted-by":"crossref","first-page":"770","DOI":"10.5858\/2001-125-0770-VZVIOT","volume":"125","author":"BK Kleinschmidt-DeMasters","year":"2001","unstructured":"Kleinschmidt-DeMasters BK, Gilden DH (2001) Varicella-zoster virus infections of the nervous system: clinical and pathologic correlates. Arch Pathol Lab Med 125:770\u2013780","journal-title":"Arch Pathol Lab Med"},{"key":"569_CR14","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1177\/1352458515576984","volume":"21","author":"R Kohlmann","year":"2015","unstructured":"Kohlmann R, Salmen A, Chan A, Knabbe C, Diekmann J, Brockmeyer N, Skaletz-Rorowski A, Michalik C, Gold R, Uberla K (2015) Serological evidence of increased susceptibility to varicella-zoster virus reactivation or reinfection in natalizumab-treated patients with multiple sclerosis. Mult Scler 21:1823\u20131832","journal-title":"Mult Scler"},{"key":"569_CR15","doi-asserted-by":"crossref","first-page":"2298","DOI":"10.1093\/brain\/awt139","volume":"136","author":"A Manouchehrinia","year":"2013","unstructured":"Manouchehrinia A, Tench CR, Maxted J, Bibani RH, Britton J, Constantinescu CS (2013) Tobacco smoking and disability progression in multiple sclerosis: United Kingdom cohort study. Brain 136:2298\u20132304","journal-title":"Brain"},{"key":"569_CR16","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.jcv.2008.08.012","volume":"44","author":"PA Maple","year":"2009","unstructured":"Maple PA, Rathod P, Smit E, Gray J, Brown D, Boxall EH (2009) Comparison of the performance of the LIAISON VZV-IgG and VIDAS automated enzyme linked fluorescent immunoassays with reference to a VZV-IgG time-resolved fluorescence immunoassay and implications of choice of cut-off for LIAISON assay. J Clin Virol 44:9\u201314","journal-title":"J Clin Virol"},{"key":"569_CR17","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1017\/S0950268801005891","volume":"127","author":"RA Marrie","year":"2001","unstructured":"Marrie RA, Wolfson C (2001) Multiple sclerosis and varicella zoster virus infection: a review. Epidemiol Infect 127:315\u2013325","journal-title":"Epidemiol Infect"},{"issue":"45","key":"569_CR18","doi-asserted-by":"crossref","first-page":"7866","DOI":"10.1016\/j.vaccine.2007.07.036","volume":"25","author":"A Nardone","year":"2007","unstructured":"Nardone A, de Oryb F, Carton M, Cohen D, van Damme P et al (2007) The comparative seroepidemiology of varicella zoster virus in 11 countries in the European region. Vaccine 25(45):7866\u20137872","journal-title":"Vaccine"},{"key":"569_CR19","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/j.clineuro.2010.04.018","volume":"112","author":"G Ordonez","year":"2010","unstructured":"Ordonez G, Martinez-Palomo A, Corona T, Pineda B, Flores-Rivera J, Gonzalez A, Chavez-Munguia B, Sotelo J (2010) Varicella zoster virus in progressive forms of multiple sclerosis. Clin Neurol Neurosurg 112:653\u2013657","journal-title":"Clin Neurol Neurosurg"},{"key":"569_CR20","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1191\/135245898678909448","volume":"4","author":"H Reiber","year":"1998","unstructured":"Reiber H, Ungefehr S, Jacobi C (1998) The intrathecal, polyspecific and oligoclonal immune response in multiple sclerosis. Mult Scler 4:111\u2013117","journal-title":"Mult Scler"},{"key":"569_CR21","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/S0895-4356(98)00030-4","volume":"51","author":"RT Ross","year":"1998","unstructured":"Ross RT (1998) The varicella-zoster virus and multiple sclerosis. J Clin Epidemiol 51:533\u2013535","journal-title":"J Clin Epidemiol"},{"key":"569_CR22","first-page":"29","volume":"26","author":"RT Ross","year":"1999","unstructured":"Ross RT, Cheang M, Landry G, Klassen L, Doerksen K (1999) Herpes zoster and multiple sclerosis. Can J Neurol Sci 26:29\u201332","journal-title":"Can J Neurol Sci"},{"key":"569_CR23","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1177\/1352458511421106","volume":"17","author":"S Sawcer","year":"2011","unstructured":"Sawcer S (2011) The major cause of multiple sclerosis is environmental: genetics has a minor role\u2014no. Mult Scler 17:1174\u20131175","journal-title":"Mult Scler"},{"key":"569_CR24","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1177\/1756285613491520","volume":"6","author":"BA Singer","year":"2013","unstructured":"Singer BA (2013) Initiating oral fingolimod treatment in patients with multiple sclerosis. Ther Adv Neurol Disord 6:269\u2013275","journal-title":"Ther Adv Neurol Disord"},{"key":"569_CR25","first-page":"214763","volume":"2011","author":"J Sotelo","year":"2011","unstructured":"Sotelo J, Corona T (2011) Varicella zoster virus and relapsing remitting multiple sclerosis. Mult Scler Int 2011:214763","journal-title":"Mult Scler Int"},{"key":"569_CR26","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1007\/s00415-006-0402-x","volume":"254","author":"J Sotelo","year":"2007","unstructured":"Sotelo J, Ordonez G, Pineda B (2007) Varicella-zoster virus at relapses of multiple sclerosis. J Neurol 254:493\u2013500","journal-title":"J Neurol"},{"key":"569_CR27","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.clineuro.2013.12.020","volume":"119","author":"J Sotelo","year":"2014","unstructured":"Sotelo J, Ordonez G, Pineda B, Flores J (2014) The participation of varicella zoster virus in relapses of multiple sclerosis. Clin Neurol Neurosurg 119:44\u201348","journal-title":"Clin Neurol Neurosurg"},{"key":"569_CR28","doi-asserted-by":"crossref","unstructured":"Torkildsen O, Power O, Storstein A (2016, 2016) Detection of varicella-zoster virus DNA during medullary and brainstem relapses in multiple sclerosis. BMJ Case Rep","DOI":"10.1136\/bcr-2016-214555"},{"key":"569_CR29","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1111\/j.1365-2141.2007.06681.x","volume":"138","author":"S Venkatachalapathy","year":"2007","unstructured":"Venkatachalapathy S, Crowe J, Gray A (2007) Atypical presentation of varicella zoster in a patient on alemtuzumab. Br J Haematol 138:406","journal-title":"Br J Haematol"}],"container-title":["Journal of NeuroVirology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s13365-017-0569-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13365-017-0569-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13365-017-0569-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,2]],"date-time":"2022-08-02T18:00:31Z","timestamp":1659463231000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s13365-017-0569-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9,11]]},"references-count":29,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["569"],"URL":"https:\/\/doi.org\/10.1007\/s13365-017-0569-1","relation":{},"ISSN":["1355-0284","1538-2443"],"issn-type":[{"value":"1355-0284","type":"print"},{"value":"1538-2443","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,9,11]]}}}